This inventor holds 1 USPTO granted patent. Top assignee: Medimmune Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Ross A. Stewart
Introduction
Ross A. Stewart is a notable inventor based in Cambridge, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of targeted binding agents. His work has implications for cancer treatment and immunotherapy.
Latest Patents
Ross A. Stewart holds a patent for "Targeted Binding Agents Against B7-H1." This innovation is crucial in the ongoing research to enhance immune responses against tumors. The patent showcases his expertise in creating solutions that address complex medical challenges.
Career Highlights
Stewart is currently employed at MedImmune Limited, a leading biotechnology company. His role involves extensive research and development, focusing on innovative therapies that can improve patient outcomes. His dedication to advancing medical science is evident in his work and contributions.
Collaborations
Throughout his career, Ross has collaborated with talented individuals such as Christophe Queva and Michelle Morrow. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
In summary, Ross A. Stewart is a distinguished inventor whose work in targeted binding agents is paving the way for advancements in cancer treatment. His contributions to MedImmune Limited and collaborations with other professionals highlight his commitment to innovation in biotechnology.